Eli Lilly is gearing up to overcome atopic dermatitis (AD) with a new biologic lebrikizumab after releasing an oral JAK inhibitor Olumiant (baricitinib).The company unveiled the results of phase 3 studies of lebrikizumab, an IL-13 inhibitor, at the 2022 American Academy of Dermatology Annual Meeting
Sandoz Korea said that it signed an exclusive sales partnership with Ilsung Pharmaceutical for the latter to market Sandoz Sugammadex Sodium Inj., a neuromuscular agent.Under the accord, Sandoz and Ilsung will supply and sell Sandoz Sugammadex Sodium Inj. to all large and general hospitals from Apri
Eli Lilly’s Janus kinase (JAK) inhibitor Olumiant (baricitinib), which recently came under safety scrutiny, demonstrated therapeutic effects on alopecia areata (AA), a study showed.On Saturday, the New England Journal of Medicine published the results of two phase 3 studies of Olumiant BRAVE-AA1 and
Roche said it confirmed the long-term efficacy and safety profile of Evrysdi (risdiplam), a treatment for spinal muscular atrophy (SMA), in a broad population of people with SMA.As the Health Insurance Review and Assessment Service (HIRA) has been reviewing reimbursement for Evrysdi for eight months
Hanmi Pharmaceutical said it would release Esomezole Plus Tab. 40/350mg, a gastroesophageal reflux disease (GORD) treatment that combined esomeprazole with magnesium hydroxide, an antacid.With the new product, Hanmi has established three types of esomeprazole – Esomezole Cap., Esomezole DR SR Cap.,
Daewoong Pharmaceutical said Monday it has submitted a new drug application (NDA) for Fexuclue, a gastroesophageal reflux disease (GERD) treatment, in the Philippines, Indonesia, and Thailand. The company prepared additional research data required by each country and applied for product approval fro
Jeil Pharmaceutical said Friday it has applied for approving Beova (ingredient: vibegron), a new drug for overactive bladder.Beova is a new drug for treating overactive bladder developed by Kyorin Pharmaceuticals in Japan. Jeil completed a phase 3 bridging clinical trial before applying for approval
SK Biopharmaceuticals said Thursday that it would double the performance in all of its business areas compared to the previous year.In an online news conference, the company’s top manager explained that major business plans for 2022 include cenobamate sales growth in the U.S., expansion into the glo
Although Korea has just approved MSD’s Lagevrio (ingredient: molnupravir) as the second oral Covid-19 treatment, attention is on how medical professionals will use it in clinical practice because of its relatively low efficacy.On Wednesday, the Ministry of Food and Drug Safety granted an emergency a
MedPacto said it appointed Dr. Timothy R. Allen, a global clinical expert, and former lead clinician at Karyopharm Therapeutics, as the executive vice president of clinical development at MedPacto Therapeutics, its U.S. offshoot.According to the company, new Vice President Allen is a clinical expert
Genexine said Thursday that it has signed a contract for the joint development and additional technology transfer with Indonesia's KG Bio for GX-E4, a long-acting biobetter candidate developed by Genexine to treat chronic kidney disease-induced anemia.The contract follows their agreement in 2015, wh
Hugel said Thursday that it has obtained product approval from the U.K. Medicines and Healthcare Products Regulatory Agency for its botulinum toxin (BTX) formulation Letybo treating forehead wrinkles.The U.K., the third European country that approved Letybo after France and Austria, is the largest B
Centenaire Biosciences, an affiliate of Medytox, said it has attracted 20 billion won ($16.4 million) in Series A investment from Bionote and SDB Investment, affiliates of SD Biosensor.Centenaire, which is developing an innovative antibody platform focused on treating cancer and immune diseases, has
Janssen Korea has completed surrendering the manufacturing licenses of eight drugs in Korea, according to government and industry officials.The eight items are Tylenol Tab. 160mg and Tylenol Tab. 80mg, Antiox Choco Tab., Stugeron Forte Cap., Stugeron Tab., and Ultracet Semi Tab., Ultracet ER Tab., a
Another immunotherapy candidate may enter Korea as GSK seeks the approval of Jemperli (Ingredient: dostarlimab-gxly), a programmed cell death receptor-1 (PD-1) blocking antibody.According to industry insiders on Tuesday, GSK is reportedly discussing its plans to apply for approval for Jemperli. If J
SK Bioscience said Monday that it signed a supply contract of GBP510, an independently developed Covid-19 vaccine candidate, with the Korea Disease Control and Prevention Agency (KDCA).The contract amount is for 10 million doses, and SK Bioscience will supply them sequentially according to the inocu
Ildong Bioscience said on Monday it exported its probiotics to Thailand for the first time in the company’s history.The Korean company recently signed an agreement with Thailand’s Milott Laboratories to supply probiotics and completed the shipping of the first batch of 600,000 units.Milott Laborator
BMS, which commercialized the world’s first immune checkpoint inhibitor Yervoy (ipilimumab) and released the second immunotherapy Opdivo (nivolumab), rolled out the third immunotherapy Opdualag.Opdualag is a fixed-dose combination drug mixing Opdivo and LAG-3 inhibitor relatlimab.On Friday, the U.S.
Medytox and Daewoong Pharmaceutical, which had fiercely fought over the origin of the latter's botulinum toxin (BTX) strain, showed improved performances after resolving their dispute in the U.S. last year.According to the audit report of both companies on Saturday, Medytox's sales increased by 31 p
Daewoong Pharmaceutical said it would team up with KB Biomed to develop an oral osteoporosis treatment.On Friday, Daewoong said it signed a joint development and license agreement with KB Biomed for synthetic or recombinant peptides of teriparatide, an osteoporosis drug. The two companies plan to de